This inventor holds 1 USPTO granted patent. Top assignees: The University of Chicago, University of California. Active years: 2013.
Company Filing History:
1 out of 961 
1 out of 15,977 
Years Active: 2013
Title: Carol Westbrook: Innovator in Cytogenetic Research
Introduction
Carol Westbrook is a distinguished inventor based in Goshen, IN (US). She has made significant contributions to the field of cytogenetics, particularly through her innovative methods for detecting genetic rearrangements. Her work has implications for cancer research and diagnostics, showcasing her commitment to advancing medical science.
Latest Patents
Westbrook holds a patent for "Chromosome-specific staining to detect genetic rearrangements." This patent involves methods and compositions for staining based on nucleic acid sequences that utilize nucleic acid probes. The methods produce staining patterns tailored for specific cytogenetic analyses. The probes are suitable for in situ hybridization and effectively stain both interphase and metaphase chromosomal material with reliable signals. The nucleic acid probes typically have a complexity greater than 50 kb, depending on the cytogenetic application. The patent also provides methods and reagents for detecting genetic rearrangements, particularly in tumor cytogenetics and the detection of disease-related loci, such as chronic myelogenous leukemia (CML).
Career Highlights
Throughout her career, Carol Westbrook has worked with prestigious institutions, including the University of California and The University of Chicago. Her research has focused on developing innovative techniques that enhance the understanding of genetic disorders and improve diagnostic capabilities.
Collaborations
Westbrook has collaborated with notable colleagues in her field, including Joe W. Gray and Daniel Pinkel. These collaborations have furthered her research and contributed to advancements in cytogenetic methodologies.
Conclusion
Carol Westbrook's contributions to cytogenetic research through her innovative patent and collaborations highlight her role as a leading inventor in the field. Her work continues to impact cancer diagnostics and genetic research, paving the way for future advancements.